人源化抗 P185(HER2) 单克隆抗体用于乳腺癌患者-猫眼课题宝

人源化抗 P185(HER2) 单克隆抗体用于乳腺癌患者

批准号：

6245056

负责人：

PABLO GONZALEZ

金额：

$1.34万

依托单位：

UNIV OF NORTH CAROLINA CHAPEL HILL

依托单位国家：

美国

项目类别：

财政年份：

1997

资助国家：

美国

项目状态：

已结题

起止时间：

1997-01-06 至 1997-11-30

来源：

https://reporter.nih.gov/project-details/6245056

关键词：

breast neoplasms clinical research drug screening /evaluation human mortality human subject human therapy evaluation monoclonal antibody neoplasm /cancer immunotherapy pathologic process quality of life recombinant proteins

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

The primary objectives of this study is to determine the overall (complete and partial) response rate. To determine time to disease progression and to further characterize the safety profile of rhuMAb HER2. The secondary objectives are to determine duration of response, determine 1-year survival estimates and to measure the quality of life of patients using the European Organization for Research and Treatment of Cancer (EORTC) quality-of-life instrument with the breast cancer module.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文

海外基金

HUMANIZED ANTI-P185(HER2) MONOCLONAL ANTIBODY IN PATIENTS WITH BREAST CANCER

项目摘要

项目成果

相似基金

相关文献